Repligen Corp (NASDAQ:RGEN)

34.75
Delayed Data
As of Apr 24
 -0.25 / -0.71%
Today’s Change
14.92
Today|||52-Week Range
35.47
+75.51%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close35.00
Today’s open35.16
Day’s range34.46 - 35.16
Volume273,883
Average volume (3 months)381,649
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+17.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio141.5
Price/Sales10.13
Price/Book10.19

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-0.48-1.27%
PDLIPDL BioPharma Inc-0.09-1.27%
KPTIKaryopharm Therapeut...-1.13-3.46%
CLLSCellectis SA-0.07-0.21%
Data as of 4:14pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers